Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Net revenue $ 34,000 [1] $ 76,000 [1]
Cost of revenue 21,000 45,000
Gross profit 13,000 31,000
Operating expenses:    
Selling and administrative expenses 311,000 714,000
Amortization of prepaid advisory fees 411,000 407,000
Research and development 107,000 290,000
Total operating expense 829,000 1,411,000
Operating loss (816,000) (1,380,000)
Other income (expense):    
Change in fair value of warrant derivative liability 81,000 1,388,000
Interest expense, net (53,000) (17,000)
Gain on settlement of accrued liability 42,000 0
Net loss $ (746,000) $ (9,000)
Net loss per common share - basic $ (0.02) $ (0.01)
Net loss per common share - diluted $ (0.02) $ (0.01)
Weighted average number of common shares outstanding - basic 47,493,619 46,172,233
Weighted average number of common shares outstanding - diluted 47,493,619 46,172,233
[1] Includes sales to related parties of approximately $3,000 and $20,000 for the three months ended September 30, 2013 and 2012, respectively.